Q/C Technologies

QCLSNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$2.712 M

$0.33 -15.32%

Close of 6 Nov 2026

As of 6 Nov 2026, Q/C Technologies (QCLS) has a market capitalization of $2.71M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$11.6M

Loss-making

Shares outstanding

8,189,838

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#15VolitionrxVNRX$5.84M
#16Cardio DiagnosticsCDIO$5.16M
#17Trinity BiotechTRIB$4.79M
#18Q/C TechnologiesQCLS$2.71M
#19Virax Biolabs GroupVRAX$1.57M

What if Q/C Technologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,447,794

Per share 10,413,151× higher

Bitcoin $1.53T

$186,554.15

Per share 563,437× higher

Apple $5.02T

$612,439.87

Per share 1,849,713× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Q/C Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.